IRIS
ARCESE, WILLIAM
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 63.914
EU - Europa 4.208
AS - Asia 1.165
SA - Sud America 24
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 12
AF - Africa 6
Totale 69.346
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 63.869
DE - Germania 1.087
UA - Ucraina 805
IE - Irlanda 725
CN - Cina 713
IT - Italia 567
KR - Corea 286
GB - Regno Unito 274
SE - Svezia 200
FI - Finlandia 165
FR - Francia 136
RU - Federazione Russa 100
PL - Polonia 52
CA - Canada 39
JP - Giappone 37
IN - India 26
BE - Belgio 21
HK - Hong Kong 20
ES - Italia 17
NL - Olanda 16
AT - Austria 14
EU - Europa 14
CL - Cile 11
IR - Iran 11
AU - Australia 10
UZ - Uzbekistan 10
VN - Vietnam 9
SG - Singapore 8
BY - Bielorussia 7
CH - Svizzera 6
MY - Malesia 6
GR - Grecia 5
MX - Messico 5
TW - Taiwan 5
BR - Brasile 4
PE - Perù 4
PK - Pakistan 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BD - Bangladesh 3
EG - Egitto 3
KG - Kirghizistan 3
LK - Sri Lanka 3
RO - Romania 3
SA - Arabia Saudita 3
AM - Armenia 2
AR - Argentina 2
CO - Colombia 2
DK - Danimarca 2
ID - Indonesia 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
QA - Qatar 2
AE - Emirati Arabi Uniti 1
CM - Camerun 1
DM - Dominica 1
EC - Ecuador 1
EE - Estonia 1
IL - Israele 1
IQ - Iraq 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
PH - Filippine 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 69.346
Salva come PNG Salva come JPEG
Città #
Wilmington 18.521
Woodbridge 17.706
Houston 16.427
Fairfield 2.175
Ann Arbor 1.553
Ashburn 990
Chandler 961
Seattle 830
Cambridge 737
Jacksonville 703
Dublin 702
Medford 544
Dearborn 461
Beijing 360
Lawrence 260
New York 198
Rome 194
San Diego 152
Regensburg 128
Mülheim 108
Milan 74
Zhengzhou 71
Menlo Park 65
London 47
Norwalk 46
Kraków 43
Redwood City 40
Hefei 37
Falls Church 36
University Park 35
Nanjing 32
Hangzhou 29
Saint Petersburg 25
Kunming 24
Redmond 23
Seoul 22
Guangzhou 21
Mountain View 21
Brussels 18
Toronto 18
Detroit 17
Verona 17
Nanchang 15
Hounslow 13
Palo Alto 13
San Mateo 13
Shanghai 13
Engelhard 12
Helsinki 12
Indiana 12
Nürnberg 12
San Francisco 12
Kilburn 11
Ottawa 11
Rieti 11
Center 10
Chiswick 10
Groningen 10
Hong Kong 10
Fuzhou 9
Petaluma 9
Prescot 9
Changsha 8
Creede 8
Jinan 8
Bari 7
Boardman 7
Bologna 7
Hebei 7
Innsbruck 7
Los Angeles 7
Minsk 7
Shenyang 7
Central 6
Kuala Lumpur 6
Washington 6
Baotou 5
Chengdu 5
Clearwater 5
Frankfurt am Main 5
Madrid 5
Munich 5
Tokyo 5
Auburn Hills 4
Birmingham 4
Brindisi 4
Chicago 4
Chongqing 4
Dong Ket 4
Islington 4
Lima 4
Melbourne 4
Montreal 4
Mumbai 4
Naples 4
Philadelphia 4
Phoenix 4
Warsaw 4
Wenzhou 4
Wuhan 4
Totale 64.899
Salva come PNG Salva come JPEG
Nome #
Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia 539
Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantation 533
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor 487
Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day+5 responders and no advantage for nonresponders receiving anti-thymocyte globulin 477
Peripheral blood stem cell collection from G-CSF-stimulated unrelated donors for second transplant 475
Unrelated cord blood transplant in children with high-risk acute lymphoblastic leukemia: a long-term follow-up 458
Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow Transplantation 443
Bowel ultrasonography as an aid for diagnosis of intestinal acute graft-versus-host-disease after allogeneic haematopoietic stem cell transplantation 429
Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation 426
Hematopoietic, Mesenchymal, and Immune Cells Are More Enhanced in Bone Marrow than in Peripheral Blood from Granulocyte Colony-Stimulating Factor Primed Healthy Donors 426
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network. 424
High levels of antiphospholipid antibodies are associated with cytomegalovirus infection in unrelated bone marrow and cord blood allogeneic stem cell transplantation 423
Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice 423
Monitoring of KI and WU polyomaviruses in hematopoietic stem cell transplant patients 414
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study 409
Cord blood transplantation in adults with acute myeloid leukaemia. 405
High expression levels of vla-4 (CD49d) on mobilised peripheral blood stem cells are associated with rapid engraftment in multiple myeloma patients receiving autologous transplant 405
A prospective molecular study of chimaerism in patients with haematological malignancies receiving unrelated cord blood or bone marrow transplants: detection of mixed chimaerism predicts graft failure with or without early autologous reconstitution in cord blood recipients 405
The therapeutic use of cord blood 404
Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study 403
Pre-transplant manipulation processing of umbilical cord blood units: Efficacy of Rubinstein's thawing technique used in 40 transplantation procedures 403
Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells 402
Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disorders 401
Obstacles to managing chemotherapy-induced nausea and vomiting in high-dose chemotherapy with stem cell transplant 399
Clinical and metabolic effects of different parenteral nutrition regimens in patients undergoing allogeneic bone marrow transplantation 399
Cryotherapy reduces oral mucositis and febrile episodes in myeloma patients treated with high-dose melphalan and autologous stem cell transplant: a prospective, randomized study 398
Pregnancy and secondary cancer after allogeneic bone marrow transplantation 397
Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT 397
Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO) 396
A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient 392
Thrombophilic screening in patients with paroxysmal nocturnal haemoglobinuria: a pilot study 392
WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO) 391
Fractionated total body irradiation in allogeneic bone marrow transplantation in leukemia patients: analysis of prognostic factors and results in 136 patients 391
A new system for quality control in hematopoietic progenitor cell units before reinfusion in autologous transplant. 391
The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant Network 390
HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemia 389
Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia 387
Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant 387
Quality assessment of cord blood units selected for unrelated transplantation: a transplant center perspective 386
Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission. 385
Hospital cluster of HBV infection: molecular evidence of patient-to-patient transmission through lancing device 385
Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation 384
Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion 383
Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey 383
Impact of ABO incompatibility on patient outcome in haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the acute leukemia working party of the EBMT 383
CD34+ cell mobilization for allogeneic progenitor cell transplantation: efficacy of a short course of G-CSF 380
The policy of the Rome Transplant Network (RTN), a metropolitan (2009). The Potential Application Of The Allogeneic Transplant By The Policy Of Widespread Donor Search: An Intention-To-Treat Analysis From The Rome Transplant Network. 378
Haploidentical, unmanipulated,G-CSF primed bona marrow transplantation for patients with high risk hematological malignancies 377
Increasing risk of relapse after allogeneic stem cell transplant for adult acute lymphoblastic leukemia in > or = 2nd complete remission induced by highly intensive chemotherapy 376
Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia 376
Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia 375
Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMT 373
A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia 373
Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis 372
Gastrointestinal surgical emergencies in patients treated for hemathological malignancies 371
Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia:a retrospective analysis. 370
Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow 370
Clinical and biological aspects of acute monocytic leukemia (a retrospective study of 29 patients) 369
Thiotepa-based conditioning for allogeneic stem cell transplantation in acute lymphoblastic leukemia—A survey from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation 369
Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant. 368
Ponatinib Induces a Persistent Molecular Response and Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia with a T315I Mutation following Early Relapse after Allogeneic Transplant 367
Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant 366
Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study 366
Algorithm for donor selection in 2011 366
Reduced intensity allogeneic transplantation in primary cutaneous t-cell lymphomas. 366
N-acetylcysteine in the treatment of steroid-resistant acute graft-versus-host-disease: preliminary results. Gruppo Italiano Trapianto di Midollo Osseo (GITMO) 364
Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia. 363
Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group 363
3-Tesla MR spectroscopy in patients subjected to bone marrow transplantation: clinical correlations. 362
Cytogenetic and molecular diagnostic characterization combined to post-consolidation minimal residual disease assessment by flow-cytometry improves risk stratification in adult acute myeloid leukemia 361
Stem cell transplantation for chronic myeloid leukemia in children 361
The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant Network. 360
Does the volume reduction manipulation before cryopreservation influence cord blood cell recovery pretransplant? 360
Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia 360
ALL R-87 protocol in the treatment of children with acute lymphoblastic leukaemia in early bone marrow relapse 359
Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid Leukemia 359
ABO-incompatible bone marrow transplantation: a GITMO survey of current practice in Italy and comparison with the literature 358
Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation 357
HLA-C and HLA-DQB1 compatibility in unrelated cord blood transplants 355
Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients 355
Risk assessment in patients with Ph+ chronic myelogenous leukemia at first relapse after allogeneic stem cell transplant: an EBMT retrospective analysis. The Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation 354
Cryptosporidiosis in patients with hematologic malignancies 354
Molecular remission in advanced acute promyelocytic leukaemia after treatment with the oral synthetic retinoid Tamibarotene 353
Transplants of Umbilical Cord Blood or Bone Marrow from Unrelated donors in Adult with Acute Leukemia 353
Monitoring treatment and survival in chronic myeloid leukemia. Italian Cooperative Study Group on Chronic Myeloid Leukemia and Italian Group for Bone Marrow Transplantation 353
Management of advanced acute lymphoblastic leukemia in children and adults: results of the ALL R-87 protocol. AIEOP and GIMEMA Cooperative Groups 352
Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study 352
Standard- versus high-dose lenograstim in adults with hematologic malignancies for peripheral blood progenitor cell mobilization. 351
Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis 351
Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Société Française de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study 351
Umbilical Cord Blood Transplantation From Unrelated Donors In Patients With Ph-Positive Acute Lymphoblastic Leukemia. 351
Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation 349
Allogeneic stem cell transplant from HLA-identical sibling for chronic granulomatous disease and review of the literature 349
Bone mass, bone metabolism, and prevalence of spinal fractures in recipients of allogenic bone marrow transplantation for leukemia 348
The Rome Transplant Network model compared to the Italian Bone Marrow Donor Registry activity for unrelated donor search process and transplant efficiency for hematologic malignancy 348
Monitoring of minimal residual disease in acute myeloid leukemia 347
Antiphospholipid Antibodies and Thrombotic Complications In Patients With Paroxysmal Nocturnal Hemoglobinuria. 347
Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial 347
Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Group (GITMO) 347
Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO 346
Totale 38.427
Salva come PNG Salva come JPEG
Categoria #
all - tutte 128.791
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 128.791
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193.668 0 0 0 0 0 0 0 0 0 0 1.943 1.725
2019/202019.443 1.552 1.530 1.309 1.654 1.630 1.997 1.635 1.520 1.687 1.728 1.694 1.507
2020/202113.162 1.504 1.493 1.484 1.740 1.350 1.517 1.678 1.251 265 364 412 104
2021/20222.502 110 380 111 102 69 197 144 139 145 157 174 774
2022/20232.801 359 243 134 265 175 672 330 137 215 17 193 61
2023/2024747 102 47 79 26 103 241 58 40 28 23 0 0
Totale 69.967